MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation Ciprian TomuleasaShigeo FujiHermann Einsele Review Article 22 April 2015 Pages: 1081 - 1092
Krüppel-like factor 1 mutations and expression of hemoglobins F and A2 in homozygous hemoglobin E syndrome Wanicha TepakhanSupawadee YamsriSupan Fucharoen Original Article 20 February 2015 Pages: 1093 - 1098
Biochemical markers of glucose metabolism may be used to estimate the degree and progression of iron overload in the liver and pancreas of patients with β-thalassemia major Munevver BasFatma GumrukSule Unal Original Article 06 March 2015 Pages: 1099 - 1104
The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia Xin ZhaoLi ZhangFengkui Zhang Original Article 19 March 2015 Pages: 1105 - 1110
Abnormalities of the lymphocyte subsets and their immunophenotype, and their prognostic significance in adult patients with hemophagocytic lymphohistiocytosis Bakul I. DalalAlok P. VakilLuke Y. C. Chen Original Article 25 March 2015 Pages: 1111 - 1117
Osteopontin: a potential biomarker of Gaucher disease Filippo VairoFernanda Sperb-LudwigIda Schwartz Original Article 01 April 2015 Pages: 1119 - 1125
Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States Bruno C. MedeirosSacha Satram-HoangCarolina Reyes Original Article Open access 20 March 2015 Pages: 1127 - 1138
Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse Nobuhiko ImahashiHaruhiko Ohashifor the Nagoya Blood and Marrow Transplantation Group Original Article 15 February 2015 Pages: 1139 - 1148
Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician’s and patient’s perspectives Jury L. ShevchenkoAlexey N. KuznetsovAndrei A. Novik Original Article 25 February 2015 Pages: 1149 - 1157
Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics Satoshi YamasakiGoichi Yoshimotofor the Fukuoka Blood and Marrow Transplantation Group Original Article 24 February 2015 Pages: 1159 - 1165
Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma Milla Elvi Linnea KuusistoKirsi-Maria HaapasaariOuti Kuittinen Original Article Open access 21 February 2015 Pages: 1167 - 1174
Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy Xi-Wen BiWen-Qi JiangZhi-Ming Li Original Article 17 February 2015 Pages: 1175 - 1184
Suggestion of response evaluation criteria in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML) Su Kyung JungJi Sun PaikSeok-Goo Cho Original Article 03 March 2015 Pages: 1185 - 1193
Trends in quality of non-Hodgkin’s lymphoma care: is it getting better? J. J. C. StienenP. B. OttevangerOn behalf of the PEARL study group Original Article Open access 15 March 2015 Pages: 1195 - 1203
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P) K. M. KortümC. LangerEsteban Braggio Original Article 07 March 2015 Pages: 1205 - 1211
Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses Yona NadirGleb SaharovTamar Shochat Original Article 07 March 2015 Pages: 1213 - 1219
Double somatic mosaic mutations in TET2 and DNMT3A—origin of peripheral T cell lymphoma in a case Tran B. NguyenMamiko Sakata-YanagimotoShigeru Chiba Letter to the Editor 17 February 2015 Pages: 1221 - 1223
HFE hemochromatosis: influence of dietary iron intake on the iron overload of C282Y homozygous patients Philippe SaliouGérald Le GacVirginie Scotet Letter to the Editor 06 March 2015 Pages: 1225 - 1227
Erythropoietin receptor mutation—a rush of blood to the head? Andreas HolbroRadek SkodaThomas Lehmann Letter to the Editor 14 March 2015 Pages: 1229 - 1231
HLA-DRB1 mismatch is associated with a decreased relapse in adult acute myeloid leukemia after single-unit myeloablative cord blood transplantation Takaaki KonumaSeiko KatoSatoshi Takahashi Letter to the Editor 11 March 2015 Pages: 1233 - 1235
Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor Joaquín Martinez-LopezAna JimenezRosa Ayala Letter to the Editor 21 March 2015 Pages: 1237 - 1239
Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman’s disease Linus AngenendtAndrea KerkhoffWolfgang E. Berdel Letter to the Editor 21 March 2015 Pages: 1241 - 1243
Retinal and central nervous system involvement in T cell large granular lymphocyte leukaemia Carol Y. M. CheungAlvin H. W. IpYok-Lam Kwong Letter to the Editor 02 April 2015 Pages: 1245 - 1246
Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab Federico SimonettaMagdalena PosaCarlo Chizzolini Letter to the Editor 07 April 2015 Pages: 1247 - 1249
CyberKnife radiosurgery leading to long-lasting complete remission in locally relapsed solitary plasmacytoma of the bone Georg TheilerVerena SchwetzHelmut H. Schmidt Letter to the Editor 10 April 2015 Pages: 1251 - 1253
De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML S. BartelsU. LehmannH. Kreipe Letter to the Editor 14 April 2015 Pages: 1255 - 1256
Successful treatment with rivaroxaban of an extended superficial vein thrombosis in a patient with acquired antithrombin deficiency due to Peg-asparaginase treatment Mark PlanderTamás SzendreiJános L. Iványi Letter to the Editor 15 April 2015 Pages: 1257 - 1258
Erratum to: A novel ELISA for diagnosis of Glanzmann’s thrombasthenia and the heterozygote carriers Vivian LoboShrimati ShettyKanjaksha Ghosh Erratum 25 April 2015 Pages: 1259 - 1259